Stimulation of catecholamine synthesis via activation of p44/42 MAPK in cultured bovine adrenal medullary cells by milnacipran

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 375, Issue 1, 2007, Pages 65-72

  Shinkai, Koji ^a   Toyohira, Yumiko ^a   Yoshimura, Reiji ^a   Tsutsui, Masato ^a   Ueno, Susume ^a   Nakamura, Jun ^a   Yanagihara, Nobuyuki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Adrenal medullary cells; Catecholamine synthesis; MAPK; Milnacipran; SNRI; SSRI; Tyrosine hydroxylase

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CARBON 14; CATECHOLAMINE; DOPA; FLUVOXAMINE MALEATE; MILNACIPRAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PAROXETINE; TYROSINE; TYROSINE 3 MONOOXYGENASE;

ADRENAL MEDULLA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE SYNTHESIS; CELL CULTURE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; IN VITRO STUDY; INCUBATION TIME; NONHUMAN; PHARMACODYNAMICS; SIGNAL TRANSDUCTION;

ADRENAL MEDULLA; ANIMALS; ANTIDEPRESSIVE AGENTS; BUTADIENES; CATECHOLAMINES; CATTLE; CELLS, CULTURED; CYCLOPROPANES; DIHYDROXYPHENYLALANINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FLUVOXAMINE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; PAROXETINE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; TYROSINE; TYROSINE 3-MONOOXYGENASE;

EID: 33847678584     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-006-0128-4     Document Type: Article

References (40)

1. 40. J Neurochem 70:2565-2573
2. Briley M, Prost JF, Moret C (1996) Preclinical pharmacology of milnacipran. Int Clin Psychopharmacol 11 (Suppl 4):9-14
3. Campbell IC, Robinson DS, Lovenberg W, Murphy DL (1979) The effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in the rat brain. J Neurochem 32:49-55
4. Carlsson A, Lindqvist M (1978) Effects of antidepressant agents on the synthesis of brain monoamines. J Neural Transm 43:73-91
5. Cooper JC, Bloom FE, Roth RH (1986) The biochemical basis of neuropharmacology. Oxford University Press, New York
6. Cryan JF, O'Leary OF, Jin S-H, Friedland JC, Ouyang M, Hirsch BR, Page ME, Dalvi A, Thomas SA, Lucki I (2004) Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proc Natl Acad Sci USA 101:8186-8191
7. Delgado PL, Miller HL, Salomon RM, Licinio J, Heninger GR, Gelenberg AJ, Charney DS (1993) Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. Psychopharmacol Bull 29:389-396
8. Duman CH, Schlesinger L, Kodama M, Russell DS, Duman RS (2006) A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol Psychiatry DOI 10.1016/j.biopsych.2006.05.047
9. Eisenhofer G, Saigusa T, Esler MD, Cox HS, Angus JA, Dorward PK (1991) Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits. Am J Physiol 260:R824-R832
10. Eisenhofer G, Friberg P, Goldstein DS, Esler M (1995) Differential actions of desipramine on sympathoadrenal release of noradrenaline and adrenaline. Br J Clin Pharmacol 40:263-265
11. Halloran SM, Vulliet PR (1994) Microtubule-associated protein kinase-2 phosphorylates and activates tyrosine hydroxylase following depolarization of bovine adrenal chromaffin cells. J Biol Chem 269:30960-30965
12. Huangfu D, Goodwin WB, Guyenet PG (1995) Sympatholytic effect of tricyclic antidepressants: site and mechanism of action in anesthetized rats. Am J Physiol 268:R1429-R1441
13. Haycock JW, Ahn NG, Cobb MH, Krebs EG (1992) ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ. Proc Natl Acad Sci USA 89:2365-2369
14. Hennings ECP, Kiss JP, Oliveira KD, Toth PT, Vizi ES (1999) Nicotinic acetylcholine receptor antagonistic activity of monoamine uptake blockers in rat hippocampal slices. J Neurochem 73:1043-1050
15. Kasper S, Pletan Y, Solles A, Tournoux A (1996) Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results. Int Clin Psychopharmacol 11 (Suppl 4):35-39
16. Lecrubier Y, Pletan Y, Solles A, Tournoux A, Magne V (1996) Clinical efficacy of milnacipran: placebo-controlled trials. Int Clin Psychopharmacol 11 (Suppl 4):29-33
17. Leonard BE (1977) Drug-induced changes in brain tyrosine hydroxylase activity in vivo. Neuropharmacol 16:47-52
18. Mercier G, Lennon AM, Renouf B, Dessouroux A, Ramauge M, Courtin F, Pierre M (2004) MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. J Mol Neurosci 24:207-216
19. Montgomery SA, Prost JF, Solles A, Briley M (1996) Efficacy and tolerability of milnacipran: an overview. Int Clin Psychopharmacol 11 (Suppl 4):47-51
20. Moret C, Briley M (1992) Effect of antidepressant drugs on monoamine synthesis in brain in vivo. Neuropharmacol 31:679-684
21. Moret C, Charveron M, Finberg JP, Couzinier JP, Briley M (1985) Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethylaminocarbonyl-2- aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug. Neuropharmacol 24:1211-1219
22. Nagatsu T, Levitt M, Udenfriend S (1964) Tyrosine hydroxylase: the initial step in norepinephrine biosynthesis. J Biol Chem 239:2910-2917
23. Nestler EJ, McMahon A, Sabban EL, Tallman JF, Duman RS (1990) Chronic antidepressant administration decreases the expression of tyrosine hydroxylase in the rat locus coeruleus. Proc Natl Acad Sci USA 87:7522-7526
24. Owens MJ, Knight DL, Nemeroff CB (2000) Paroxetine binding to the rat norepinephrine transporter in vivo. Biol Psychiatry 47:842-845
25. Puozzo C, Albin H, Vincon G, Deprez D, Raymond JM, Amouretti M (1997) Pharmacokinetics of milnacipran in liver impairment. Eur J Drug Metab Pharmacokinet 23:273-279
26. Shinkai K, Yoshimura R, Ueda N, Okamoto K, Nakamura J (2004) Associations between baseline plasma MHPG (3-methoxy-4-hydroxyphenylglycol) levels and clinical responses with respect to milnacipran versus paroxetine treatment. J Clin Psychopharmacol 24:11-17
27. Shinkai K, Yoshimura R, Toyohira Y, Ueno S, Tsutsui M, Nakamura J, Yanagihara N (2005) Effect of prolonged exposure to milnacipran on norepinephrine transporter in cultured bovine adrenal medullary cells. Biochem Pharmacol 70:1389-1397
28. Stenger A, Couzinier JP, Briley M (1987) Psychopharmacology of midalcipran, 1-phenyl-1-diethyl-amino-carbonyl-2-aminomethylcyclopropane hydrochloride (F 2207), a new potential antidepressant. Psychopharmacol (Berl) 91:147-153
29. Terao T, Yanagihara N, Abe K, Izumi F (1992) Lithium chloride stimulates catecholamine synthesis and secretion in cultured bovine adrenal medullary cells. Biol Psychiatry 31:1038-1049
30. Tolbert LM, Russel DS, Duman RS (2003) Norepinephrine activates extracellular-regulated kinase in cortical neurons. Biol Psychiatry 54:983-993
31. Tollefson GD, Rosenbaum FR (1998) Selective serotonin reuptake inhibitors. In: Schatzberg AF, Nemeroff CB (eds) Textbook of psychopharmacology. American Psychiatric Press, Washington, DC pp 219-237
32. Toyohira Y, Kubo T, Watanabe M, Uezono Y, Ueno S, Shinkai K, Tsutsui M, Izumi F, Yanagihara N (2005) Selective blockade of nicotinic acetylcholine receptors by pimobendan, a drug for the treatment of heart failure: reduction of catecholamine secretion and synthesis in adrenal medullary cells. Naunyn-Schmiedeberg's Arch Pharmacol 371:107-113
33. Ueta K, Suzuki T, Uchida I, Mashimo T (2004) In vitro inhibition of recombinant ligand-gated ion channels by high concentrations of milnacipran. Psychopharmacol 175:241-246
34. Weiner N (1970) Regulation of norepinephrine biosynthesis. Annu Rev Pharmacol 10:273-290
35. Yanagihara N, Isosaki M, Ohuchi T, Oka M (1979) Muscarinic receptor-mediated increase in cyclic GMP level in isolated bovine adrenal medullary cells. FEBS Lett 105:296-298
36. 2+ in cultured bovine adrenal medullary cells. J Biol Chem 271:17463-17468
37. Yanagihara N, Toyohira Y, Ueno S, Tsutsui M, Utsunomiya K, Liu M, Tanaka K (2005) Stimulation of catecholamine synthesis by environmental estrogenic pollutants. Endocrinol 146:265-272
38. Yoshida K, Takahashi H, Higuchi H, Kamata M, Ito K, Sato K, Naito S, Shimizu T, Itoh K, Inoue K, Suzuki T, Nemeroff CB (2004) Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms. Am J Psychiatry 161:1575-1580
39. Yoshimura R, Yanagihara N, Hara K, Nakamura J, Toyohira Y, Ueno S, Izumi F (2001) Dual phases of functional changes in norepinephrine transporter in cultured bovine adrenal medullary cels by long-term treatment with clozapine. J Neurochem 77:1018-1026
40. Zigmond RE, Schwarzschild MA, Rittenhouse AR (1989) Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation. Annu Rev Neurosci 12:415-461